Medication effectiveness relies on patient adherence to a given treatment regimen. Often, patients do not adhere to the temporal guidelines set by their physicians and treatments therefore remain less effective. In situ forming implants (ISFIs) eliminate the need for patient adherence and release an effective dose of drug overtime. However, no methods exist to noninvasively and temporally validate drug release in vivo. We conducted in vivo experiments that validated the use of DWI to monitor ISFI diffusivity overtime. This has enormous implications in pharmaceutical research as this method can robustly quantify diffusivity in ISFIs post-implantation to ensure effective drug release.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords